BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38403420)

  • 1. [Correlation between prognostic nutritional index and pleural thickness with survival time of epithelial malignant pleural mesothelioma patients].
    Zhou JH; Zhang YL; Li LF; Lu PL
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2024 Feb; 42(2):118-123. PubMed ID: 38403420
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma.
    Yao ZH; Tian GY; Wan YY; Kang YM; Guo HS; Liu QH; Lin DJ
    J Cancer Res Clin Oncol; 2013 Dec; 139(12):2117-23. PubMed ID: 24149776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleural thickness after neoadjuvant chemotherapy is a prognostic factor in malignant pleural mesothelioma.
    Hashimoto M; Takeuchi J; Takuwa T; Kuroda A; Nakamura A; Nakamichi T; Matsumoto S; Kondo N; Nakano T; Morimoto T; Hasegawa S
    J Thorac Cardiovasc Surg; 2019 Jan; 157(1):404-413. PubMed ID: 30557956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed tomography in the evaluation of malignant pleural mesothelioma-Association of tumor size to a sarcomatoid histology, a more advanced TNM stage and poor survival.
    Paajanen J; Laaksonen S; Ilonen I; Wolff H; Husgafvel-Pursiainen K; Kuosma E; Ollila H; Myllärniemi M; Vehmas T
    Lung Cancer; 2018 Feb; 116():73-79. PubMed ID: 29413055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development and validation of prognostic nomogram for malignant pleural mesothelioma].
    Xie XJ; Chen JY; Jiang J; Duan H; Wu Y; Zhang XW; Yang SJ; Zhao W; Shen SS; Wu L; He B; Ding YY; Luo H; Liu SY; Han D
    Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):415-423. PubMed ID: 37188627
    [No Abstract]   [Full Text] [Related]  

  • 6. Malignant pleural mesothelioma: diagnostic value of medical thoracoscopy and long-term prognostic analysis.
    Xu LL; Yang Y; Wang Z; Wang XJ; Tong ZH; Shi HZ
    BMC Pulm Med; 2018 Apr; 18(1):56. PubMed ID: 29615010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of CD24 gene in human malignant pleural mesothelioma and its relationship with prognosis].
    Li B; Zhou CX; Pu YQ; Qiu L; Mei W; Xiong W
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Mar; 41(3):168-176. PubMed ID: 37006141
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical, Laboratory, Histological, Radiological, and Metabolic Features and Prognosis of Malignant Pleural Mesothelioma.
    Zhang Y; Li R; Gu Y; LiZhu Y; Liu X; Zhang S
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557076
    [No Abstract]   [Full Text] [Related]  

  • 9. A prognostic score for patients with malignant pleural mesothelioma (MPM) receiving second-line immunotherapy or chemotherapy in the ETOP 9-15 PROMISE-meso phase III trial.
    Banna GL; Addeo A; Zygoura P; Tsourti Z; Popat S; Curioni-Fontecedro A; Nadal E; Shah R; Pope A; Fisher P; Spicer J; Roy A; Gilligan D; Gautschi O; Janthur WD; López-Castro R; Roschitzki-Voser H; Dafni U; Peters S; Stahel RA
    Lung Cancer; 2022 Jul; 169():77-83. PubMed ID: 35660972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of TGF-β in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesothelioma.
    Stockhammer P; Ploenes T; Theegarten D; Schuler M; Maier S; Aigner C; Hegedus B
    Lung Cancer; 2020 Jan; 139():124-132. PubMed ID: 31778960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent lung expansion after pleural talc poudrage in non-surgically resected malignant pleural mesothelioma.
    Rena O; Boldorini R; Papalia E; Mezzapelle R; Baietto G; Roncon A; Casadio C
    Ann Thorac Surg; 2015 Apr; 99(4):1177-83. PubMed ID: 25669666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the LENT score risk-stratify patients with malignant pleural mesothelioma? An observational study.
    Chollet B; Guinde J; Laroumagne S; Dutau H; Astoul P
    Thorac Cancer; 2021 Jun; 12(11):1752-1756. PubMed ID: 33949775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index.
    Kataoka Y; Yamamoto Y; Otsuki T; Shinomiya M; Terada T; Fukuma S; Yamazaki S; Hirabayashi M; Nakano T; Fukuhara S
    Jpn J Clin Oncol; 2015 Jun; 45(6):562-8. PubMed ID: 25838292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleural effusion biomarkers and computed tomography findings in diagnosing malignant pleural mesothelioma: A retrospective study in a single center.
    Otoshi T; Kataoka Y; Ikegaki S; Saito E; Matsumoto H; Kaku S; Shimada M; Hirabayashi M
    PLoS One; 2017; 12(10):e0185850. PubMed ID: 28968445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and prognostic features of erionite-induced malignant mesothelioma.
    Demirer E; Ghattas CF; Radwan MO; Elamin EM
    Yonsei Med J; 2015 Mar; 56(2):311-23. PubMed ID: 25683976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of clinicopathological features of 68 cases of malignant pleural mesothelioma].
    Mei W; Yang SJ; Zhang YP; Fu QS; Xiong W; Zhao Y
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Aug; 41(8):588-593. PubMed ID: 37667154
    [No Abstract]   [Full Text] [Related]  

  • 17. Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis.
    Lococo F; Torricelli F; Lang-Lazdunski L; Veronesi G; Rena O; Paci M; Casadio C; Piana S; Novellis P; Di Stefano TS; Ciarrocchi A; Billè A
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1584-1593.e2. PubMed ID: 31590954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between prognosis and neutrophil: lymphocyte and platelet:lymphocyte ratios in patients with malignant pleural mesotheliomas.
    Cihan YB; Ozturk A; Mutlu H
    Asian Pac J Cancer Prev; 2014; 15(5):2061-7. PubMed ID: 24716935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of pemetrexed and bevacizumab intrapleural injection for malignant pleural mesothelioma-mediated malignant pleural effusion.
    Chen D; Li X; Zhao H; Fu Y; Yao F; Hu J; Du N
    Indian J Cancer; 2014 Mar; 51 Suppl 3():e82-5. PubMed ID: 25818740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in Survival Due to Social Determinants of Health and Access to Treatment in US Patients With Operable Malignant Pleural Mesothelioma.
    Alnajar A; Kareff SA; Razi SS; Rao JS; De Lima Lopes G; Nguyen DM; Villamizar N; Rodriguez E
    JAMA Netw Open; 2023 Mar; 6(3):e234261. PubMed ID: 36951862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.